MetaADEDB 2.0 @ LMMD
talazoparib
(HWGQMRYQVZSGDQ-HZPDHXFCSA-N)
Structure
SMILES
Fc1ccc(cc1)[C@H]1Nc2cc(F)cc3c2c([C@@H]1c1ncnn1C)n[nH]c3=O
Type(s)
Approved; Investigational
ATC code(s)
L01XX60
Molecular Formula:
C19H14F2N6O
Molecular Weight:
380.351
Log P:
2.7665
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
2
TPSA:
88.49
CAS Number(s):
1207456-01-6
Synonym(s)
1.
talazoparib
2.
BMN 673
3.
BMN-673
4.
BMN673
External Link(s)
MeSHC586365
PubChem Compound135565082
44819241
BindingDB50084621
CHEMBLCHEMBL3137320
DrugBankDB11760
IUPHAR/BPS Guide to PHARMACOLOGY8313
KEGGdr:D10732
Therapeutic Target DatabaseD0X5LR
ZINC72318110
138126699
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 5US FAERS
2FatigueFAERS: 4US FAERS
3Product use in unapproved indicationFAERS: 3US FAERS
4AlopeciaFAERS: 2US FAERS
5Full blood count decreasedFAERS: 2US FAERS
6NeutropeniaFAERS: 2US FAERS
7ThrombocytopeniaFAERS: 2US FAERS
8VomitingFAERS: 2US FAERS
9Abdominal PainFAERS: 1US FAERS
10CytopeniaFAERS: 1US FAERS
11DehydrationFAERS: 1US FAERS
12Febrile NeutropeniaFAERS: 1US FAERS
13Gene MutationFAERS: 1US FAERS
14HeadacheFAERS: 1US FAERS
15LeukopeniaFAERS: 1US FAERS
16Liver function test decreasedFAERS: 1US FAERS
17MalaiseFAERS: 1US FAERS
18MydriasisFAERS: 1US FAERS
19Product use issueFAERS: 1US FAERS
20Radiation injuryFAERS: 1US FAERS
21Therapy cessationFAERS: 1US FAERS
22Visual ImpairmentFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.